Dec 3 (Reuters) - Neuren Pharmaceuticals Ltd NEU.AX :
* EUROPEAN PATENT OFFICE HAS ISSUED A NOTICE OF ALLOWANCE FOR A NEW PATENT COVERING NNZ-2591 TO TREAT NEURODEVELOPMENTAL DISORDERS
* DEVELOPING NNZ-2591 TO TREAT THREE DEBILITATING CHILDHOOD DISORDERS